Akers Biosciences, Inc. (55) | Employment Agreements (12)
Recent Contracts
-
Amendment No. 4 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals, Inc., dated November 24, 2021
(Filed With SEC on March 31, 2022)
-
Amendment No. 2 to Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals, Inc., dated November 24, 2021
(Filed With SEC on March 31, 2022)
-
Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals (Florida), Inc., effective December 18, 2020
(Filed With SEC on May 18, 2021)
-
Amendment No. 1 to Employment Agreement between Adam Kaplin and MyMD Pharmaceuticals (Florida), Inc, dated February 11, 2021
(Filed With SEC on May 18, 2021)
-
Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., effective November 1, 2020
(Filed With SEC on May 18, 2021)
-
Amendment No. 1 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., dated December 18, 2020
(Filed With SEC on May 18, 2021)
-
Amendment No. 2 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., dated January 8, 2021
(Filed With SEC on May 18, 2021)
-
Amendment No. 3 to Employment Agreement between Chris Chapman and MyMD Pharmaceuticals (Florida), Inc., dated February 11, 2021
(Filed With SEC on May 18, 2021)
-
Employment Agreement between Paul Rivard and MyMD Pharmaceuticals (Florida), Inc., dated September 21, 2020
(Filed With SEC on May 18, 2021)
-
Amendment No. 1 to Employment Agreement between Paul Rivard and MyMD Pharmaceuticals (Florida), Inc., dated November 24, 2020
(Filed With SEC on May 18, 2021)
-
Amendment No. 2 to Employment Agreement between Paul Rivard and MyMD Pharmaceuticals (Florida), Inc., dated December 18, 2020
(Filed With SEC on May 18, 2021)
-
Offer of Employment, dated January 6, 2020
(Filed With SEC on January 6, 2020)